Literature DB >> 8243854

Effect of metabolic factors and blood pressure on kidney function in proteinuric type 2 (non-insulin-dependent) diabetic patients.

C Hasslacher1, A Bostedt-Kiesel, H P Kempe, P Wahl.   

Abstract

Decline of kidney function with time and its influencing factors were investigated in the present longitudinal study in Type 2 (non-insulin-dependent) diabetic patients with clinical diabetic nephropathy. Compared to a control group of Type 2 diabetic patients without proteinuria, the proteinuric patients showed a higher prevalence of hypertension, higher systolic blood pressure values and serum triglyceride levels. The annual loss of glomerular kidney function was much higher in the proteinuric patients (5.3 ml.min-1 x 1.73 m2) than in the control subjects (0.9 ml.min-1 x 1.73 m2). Correlation analyses revealed a close correlation between the annual decrease of kidney function and the factors, systolic and diastolic blood pressure, triglyceride and postprandial blood glucose level as well as body mass index. Regression analyses showed for the first time that in addition to the systolic blood pressure and metabolic control, the triglyceride level is also an independent factor influencing the progression of nephropathy. Higher values of these parameters were associated with a more rapid deterioration of kidney function.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8243854     DOI: 10.1007/bf02374498

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  29 in total

1.  Profile of patients on RRT in Europe and death rates due to major causes of death groups. The EDTA Registration Committee.

Authors:  F P Brunner; N H Selwood
Journal:  Kidney Int Suppl       Date:  1992-10       Impact factor: 10.545

2.  Partial remission of nephrotic syndrome in patient on long-term simvastatin.

Authors:  A J Rabelink; R J Hené; D W Erkelens; J A Joles; H A Koomans
Journal:  Lancet       Date:  1990-04-28       Impact factor: 79.321

3.  Relation between serum cholesterol and diabetic nephropathy.

Authors:  H Mulec; S A Johnson; S Björck
Journal:  Lancet       Date:  1990-06-23       Impact factor: 79.321

4.  Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians.

Authors:  C L Kunzelman; W C Knowler; D J Pettitt; P H Bennett
Journal:  Kidney Int       Date:  1989-02       Impact factor: 10.612

5.  Effect of antihypertensive treatment on kidney function in diabetic nephropathy.

Authors:  H H Parving; A R Andersen; U M Smidt; E Hommel; E R Mathiesen; P A Svendsen
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-06

6.  Comparison of type II and type I diabetics treated for end-stage renal disease in a large prepaid health plan population.

Authors:  J D Ordonez; R A Hiatt
Journal:  Nephron       Date:  1989       Impact factor: 2.847

7.  Similar risks of nephropathy in patients with type I or type II diabetes mellitus.

Authors:  C Hasslacher; E Ritz; P Wahl; C Michael
Journal:  Nephrol Dial Transplant       Date:  1989       Impact factor: 5.992

8.  Prospective study of the impact of hypertension upon kidney function in diabetes mellitus.

Authors:  W G Walker; J Hermann; R P Murphy; R P Russell
Journal:  Nephron       Date:  1990       Impact factor: 2.847

9.  Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients.

Authors:  H H Parving; M A Gall; P Skøtt; H E Jørgensen; H Løkkegaard; F Jørgensen; B Nielsen; S Larsen
Journal:  Kidney Int       Date:  1992-04       Impact factor: 10.612

10.  Accurate estimation of glomerular filtration rate in diabetic nephropathy from age, body weight, and serum creatinine.

Authors:  M J Sampson; P L Drury
Journal:  Diabetes Care       Date:  1992-05       Impact factor: 19.112

View more
  10 in total

Review 1.  Management of diabetic nephropathy.

Authors:  L Foggensteiner; S Mulroy; J Firth
Journal:  J R Soc Med       Date:  2001-05       Impact factor: 5.344

Review 2.  Glycemic control and burnt-out diabetes in ESRD.

Authors:  Csaba P Kovesdy; Jong C Park; Kamyar Kalantar-Zadeh
Journal:  Semin Dial       Date:  2010-03-30       Impact factor: 3.455

3.  Prevalence of microalbuminuria and its correlates among diabetic patients attending diabetic clinic at National Guard Hospital in Alhasa.

Authors:  Aneesah A AlFehaid
Journal:  J Family Community Med       Date:  2017 Jan-Apr

Review 4.  [Protection of renal function in diabetics].

Authors:  C Hasslacher
Journal:  Internist (Berl)       Date:  2007-07       Impact factor: 0.743

Review 5.  The relationship between glucose control and the development and progression of diabetic nephropathy.

Authors:  Carrie A Phillips; Mark E Molitch
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 6.  [Diabetic complications. Micro and macroangiopathic end-organ damage].

Authors:  U D Lichtenauer; J Seissler; W A Scherbaum
Journal:  Internist (Berl)       Date:  2003-07       Impact factor: 0.743

7.  Effect of zinc supplementation on microalbuminuria in patients with type 2 diabetes: a double blind, randomized, placebo-controlled, cross-over trial.

Authors:  Mahmoud Parham; Massoud Amini; Ashraf Aminorroaya; Esfandiar Heidarian
Journal:  Rev Diabet Stud       Date:  2008-08-10

Review 8.  Management of high-risk hypertensive patients with diabetes: potential role of angiotensin II receptor antagonists.

Authors:  M A Weber; M R Weir
Journal:  J Clin Hypertens (Greenwich)       Date:  2001 Jul-Aug       Impact factor: 3.738

9.  Serum 1,5-anhydroglucitol concentrations are a reliable index of glycemic control in type 2 diabetes with mild or moderate renal dysfunction.

Authors:  Won Jun Kim; Cheol-Young Park; Kyu-Beck Lee; Se Eun Park; Eun Jung Rhee; Won Young Lee; Ki Won Oh; Sung Woo Park
Journal:  Diabetes Care       Date:  2011-12-30       Impact factor: 19.112

10.  Microalbuminuria among Type 1 and Type 2 diabetic patients of African origin in Dar Es Salaam, Tanzania.

Authors:  Janet Joy Kachuchuru Lutale; Hrafnkell Thordarson; Zulfiqarali Gulam Abbas; Kåre Vetvik
Journal:  BMC Nephrol       Date:  2007-01-15       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.